Abbott Laboratories ABT
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.34% | 12.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.34% | 12.80% | |||
| Cost of Revenue | 5.69% | 8.90% | |||
| Gross Profit | 1.61% | 15.84% | |||
| SG&A Expenses | 6.23% | 7.96% | |||
| Depreciation & Amortization | 27.81% | 55.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.03% | 11.19% | |||
| Operating Income | -18.09% | 23.14% | |||
| Income Before Tax | -19.23% | 5.18% | |||
| Income Tax Expenses | -47.82% | 60.22% | |||
| Earnings from Continuing Operations | -0.86% | -13.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.86% | -13.83% | |||
| EBIT | -18.09% | 23.14% | |||
| EBITDA | -4.77% | 26.22% | |||
| EPS Basic | -0.53% | -13.74% | |||
| Normalized Basic EPS | -18.95% | 5.31% | |||
| EPS Diluted | 0.00% | -13.11% | |||
| Normalized Diluted EPS | -18.99% | 5.42% | |||
| Average Basic Shares Outstanding | -0.34% | -0.12% | |||
| Average Diluted Shares Outstanding | -0.29% | -0.23% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.00% | 0.16% | |||